Table 1.
Sex of Offspring of Cancer Survivors (Stratified by Type of Treatment Received) and of Sibling Controls
No. of Offspring ofSurvivors Who Receiveda,b |
No. of Offspring ofSurvivors Who Receivedc |
||||
Sex of OffspringStratified bySex of Subjects | PotentiallyMutagenicTherapy | Less- orNonmutagenicTherapy | No. of Offspring of Sibling Controlsb | PotentiallyMutagenicTherapy | Less- orNonmutagenicTherapy |
Male subjects: | |||||
Male offspring | 100 | 344 | 1,022 | 137 | 529 |
Female offspring | 94 |
340 |
1,021 |
141 |
522 |
Subtotal (sex ratio) | 194 (1.06) | 684 (1.01) | 2,043 (1.00) | 278 (0.97) | 1,051 (1.01) |
Female subjects: | |||||
Male offspring | 98 | 513 | 1,278 | 140 | 794 |
Female offspring | 116 |
498 |
1,223 |
165 |
731 |
Subtotal (sex ratio) | 214 (0.84) |
1,011 (1.03) |
2,501 (1.04) |
305 (0.85) |
1,525 (1.09) |
Total | 408 | 1,695 | 4,544 | 583 | 2,576 |
The sum of offspring of survivors treated with potentially mutagenic therapy and those treated with less- or nonmutagenic therapy is slightly less than the total number of offspring of the survivors, because the site of radiotherapy, in some patients, was not known.
Data on offspring of subjects from original study (Byrne et al. 1998).